After speculation following one of the biggest scandals in the nascent Canadian marijuana industry, Ontario-based cannabis producer CannTrust Holdings (NYSE:CTST,TSX:TRST) confirmed its licenses were suspended on Tuesday (September 17).

CannTrust informed its investors the company received a notice from federal regulators for the suspension of its license earlier on Tuesday, all for its violations of the Cannabis Act. The company was originally found to have started unlicensed growing at its Pelham, Ontario, facility.


Shares of the cannabis firm in Toronto tanked by double digits after being halted by regulators at 11:32 a.m. EDT. As of 3:59 p.m. EDT, the company was valued at C$1.70 per share, representing a nearly 15 percent drop for the day.

“The notice states that Health Canada has suspended CannTrust’s authority to produce cannabis, other than cultivating and harvesting, and to sell cannabis,” the firm said in a statement.

On Wednesday’s (September 18) trading session, CannTrust bounced back in Toronto, closing the day with a 1.18 percent recovery for a price per share of C$1.72.

CannTrust will continue to cultivate and harvest existing cannabis yields and conduct ancillary activities in the market. However, the suspension will partially affect CannTrust’s license for standard cultivation and fully halt the company’s processing, medical sales and cannabis research operations.

The cannabis company told investors its license would be reinstated by Health Canada once it can prove its has fully dealt with the reasons behind the suspension.

Health Canada also suggested measures, including controlling the movement of the drug in and out of CannTrust’s facilities and making sure key personnel within the company are fully aware of the provisions of the Cannabis Act that regulate the company’s operations.

The company said its management was reviewing the notice with company counsel and other advisors.

The troubles for CannTrust started in July when its Pelham, Ontario, was found to be non-compliant by Health Canada after it was discovered cannabis was being grown in rooms that were unlicensed.

From there, the reputation of the company fell further as more information about the scandal was revealed.

Any investor value for the firm was shattered following the initial confirmation of wrongdoing. Since the first announcement from the cannabis company, its Canadian shares plummeted over 60 percent in value.

An investigation by the Globe and Mail found that high-level executives in the company, including former CEO Peter Aceto and former chairman Eric Paul, were aware of the illegal growing operations.

The discovery, and an internal review of the company, lead to Paul’s forced resignation and the firing of Aceto, who was then replaced by Robert Marcovitch as interim CEO.

In the fallout, thousands of kilograms of CannTrust cannabis were put on hold. Ontario and Alberta also pulled the company’s products from shelves, and CannTrust’s Danish partner quarantined its stock.

Ontario later returned C$2.9 million dollars worth of cannabis product from the company, saying these were “non-conforming products” and didn’t comply with its master cannabis supply agreement with CannTrust.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less